.

Name : Mrs. MAMTA SHUKLA Age : 42 Years

Lab No. : 454015753 Gender : Female
Ref By : SELF Reported : 10/9/2023 2:03:43AM
Collected : 9/9/2023 10:10:00AM Report Status : Final
A/c Status : P
Collected at : NOIDA II, (SECTOR 50) Processed at : LPL-NATIONAL REFERENCE LAB
B-1/1, Central Market, Sec-50, Noida-201304 T. National Reference laboratory, Block E, Sector
LTD, Phone no.-0120-3988505 18, Rohini, New Delhi -110085
NOIDA

Test Report

Test Name Results Units Bio. Ref. Interval

TYPHIDOT / SALMONELLA TYPHI, IgG

(ICT)

TYPHIDOT / SALMONELLA TYPHI_ IgG Reactive

Interpretation
-----------------------------------------------------------------------------------------------
| RESULT | REMARKS |
|--------------|--------------------------------------------------------------------------------|
| Reactive | Indicates presence of IgG antibodies against Salmonella typhi and/or paratyphi.|
|--------------|--------------------------------------------------------------------------------|
| Non-Reactive | Indicates absence of IgG antibodies against Salmonella typhi and/or paratyphi. |
-----------------------------------------------------------------------------------------------

Note
1. Positive results are seen in past/chronic Enteric fever caused by Salmonella typhi and/or paratyphi or
immunized individuals.
2. Negative results are seen in absence of Salmonella typhi and/or paratyphi infection. However, it does
not rule out the disease.
3. False positive results may be due to cross reactivity with other Salmonella spp., Dengue virus infection
& in patients with high levels of heterophile antibodies or Rheumatoid factor.
4. False negative reaction may be due to processing of sample collected early in the course of disease,
suboptimal level of antibodies and immunosuppression.
5. The results obtained with this test should only be interpreted in conjunction with other diagnostic
procedures and clinical findings.
6. Test conducted on serum.

Uses
· To diagnose chronic or past infection due to Salmonella typhi and/or paratyphi (Enteric fever).
· To assess response to typhoid vaccination.

Dr Shalabh Malik Dr Puneeta Singh

MD, Microbiology
Technical Director - Microbiology,
Infectious Disease Molecular &
Serology, Clinical Pathology
NRL - Dr Lal PathLabs Ltd
Ph.D (Microbiology)
Principal Research Scientist
NRL - Dr Lal PathLabs Ltd

*454015753* Page 1 of 7
.

Name : Mrs. MAMTA SHUKLA

Lab No. : 454015753 Age : 42 Years
Ref By : SELF Gender : Female
Collected : 9/9/2023 10:10:00AM Reported : 10/9/2023 2:03:43AM
A/c Status : P Report Status : Final
Collected at : NOIDA II, (SECTOR 50) Processed at : LPL-NOIDA LAB
B-1/1, Central Market, Sec-50, Noida-201304 T. N-27, SECTOR-18, NOIDA - 201301
LTD, Phone no.-0120-3988505
NOIDA

Test Report

Test Name Results Units Bio. Ref. Interval

TYPHIDOT/SALMONELLA TYPHI IgG & IgM

TYPHI DOT/ SALMONELLA TYPHI IgM Negative

(ICT)

Interpretation
-------------------------------------------------------------------------------
| RESULT | REMARKS |
|--------------|----------------------------------------------------------------|
| Reactive | Indicates presence of IgM antibodies against Salmonella typhi. |
|--------------|----------------------------------------------------------------|
| Non-Reactive | Indicates absence of IgM antibodies against Salmonella typhi. |
-------------------------------------------------------------------------------

Note:
1.Its positivity in serum indicates ongoing or recent infection by Salmonella typhi and the diagnosis
should be confirmed by gold standard test such as Blood culture prior to start of antibiotics.
2.IgM antibodies are typically detectable 5-7 days post symptom onset, peaking in 2nd week and
frequently remain elevated for 2-4 months following infection.
3.False positive results may be due to cross reactivity with other Salmonella spp., Dengue virus
infection & in patients with high levels of Rheumatoid factor.
4. False negative reaction may be due to processing of sample collected early in the course of
disease, antibiotic treatment during 1st week and immunosuppression.
5. Test conducted on serum.

Use
· To diagnose infection due to Salmonella typhi (Enteric fever).

TSH, ULTRASENSITIVE, SERUM 4.023 µIU/mL 0.550 - 4.780

(Chemiluminescent Immunoassay)

Note
1. TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a
minimum between 6-10 pm . The variation is of the order of 50%, hence time of the day has influence
on the measured serum TSH concentrations.
2. Values <0.03 µIU/mL need to be clinically correlated due to presence of a rare TSH variant in some
individuals.
3. Transient increase in TSH levels or abnormal TSH levels can be seen in various nonthyroidal
diseases. Simultaneous measurement of TSH with free T4 is useful in evaluating the differential
diagnosis

*454015753* Page 2 of 7
.

Name : Mrs. MAMTA SHUKLA

Lab No. : 454015753 Age : 42 Years
Ref By : SELF Gender : Female
Collected : 9/9/2023 10:10:00AM Reported : 10/9/2023 2:03:43AM
A/c Status : P Report Status : Final
Collected at : NOIDA II, (SECTOR 50) Processed at : LPL-NOIDA LAB
B-1/1, Central Market, Sec-50, Noida-201304 T. N-27, SECTOR-18, NOIDA - 201301
LTD, Phone no.-0120-3988505
NOIDA

Test Report

Test Name Results Units Bio. Ref. Interval

Interpretation
------------------------------------------------------
| REFERENCE GROUP | REFERENCE RANGE in µIU/mL |
| | (As per American Thyroid |
| | Association) |
|--------------------------|---------------------------|
| Pregnancy | |
| | |
| 1st Trimester | 0.100 - 2.500 |
| 2nd Trimester | 0.200 - 3.000 |
| 3rd Trimester | 0.300 - 3.000 |
| | |
------------------------------------------------------

*454015753* Page 3 of 7
.

Name : Mrs. MAMTA SHUKLA

Lab No. : 454015753 Age : 42 Years
Ref By : SELF Gender : Female
Collected : 9/9/2023 10:10:00AM Reported : 10/9/2023 2:03:43AM
A/c Status : P Report Status : Final
Collected at : NOIDA II, (SECTOR 50) Processed at : LPL-NOIDA LAB
B-1/1, Central Market, Sec-50, Noida-201304 T. N-27, SECTOR-18, NOIDA - 201301
LTD, Phone no.-0120-3988505
NOIDA

Test Report

Test Name Results Units Bio. Ref. Interval

LIPID PROFILE, BASIC, SERUM

Cholesterol Total 161 mg/dL <200.00

(CHO-POD)
Triglycerides 382 mg/dL <150.00
(GPO)
HDL Cholesterol 31 mg/dL >50.00
(Homogenous assay)
LDL Cholesterol,Direct 89 mg/dL <100.00
(Homogenous assay)
VLDL Cholesterol 76 mg/dL <30.00
(Calculated)
Non-HDL Cholesterol 130 mg/dL <130.00
(Calculated)

Note
1. Measurements in the same patient can show physiological & analytical variations. Three serial
samples 1 week apart are recommended for Total Cholesterol, Triglycerides, HDL & LDL Cholesterol.
2. Lipid Association of India (LAI) recommends screening of all adults above the age of 20 years for
Atherosclerotic Cardiovascular Disease (ASCVD) risk factors especially lipid profile. This should be
done earlier if there is family history of premature heart disease, dyslipidemia, obesity or other risk
factors

ASCVD Risk Stratification & Treatment goals in Indian population

1. Indians are at very high risk of developing ASCVD, they usually get the disease at an early age,
have a more severe form of the disease and have poorer outcome as compared to the western
populations
2. Many individuals remain asymptomatic before they get heart attack, ASCVD risk helps to identify
high risk individuals even when there is no symptom related to heart disease
3. ASCVD risk category helps clinician to decide when to consider therapy and what should be the
treatment goal

Treatment Goals as per Lipid Association of India 2020

*454015753* Page 4 of 7
.

Name : Mrs. MAMTA SHUKLA

Lab No. : 454015753 Age : 42 Years
Ref By : SELF Gender : Female
Collected : 9/9/2023 10:10:00AM Reported : 10/9/2023 2:03:43AM
A/c Status : P Report Status : Final
Collected at : NOIDA II, (SECTOR 50) Processed at : LPL-NOIDA LAB
B-1/1, Central Market, Sec-50, Noida-201304 T. N-27, SECTOR-18, NOIDA - 201301
LTD, Phone no.-0120-3988505
NOIDA

Test Report

Test Name Results Units Bio. Ref. Interval

--------------------------------------------------------------------------------------------
| | CONSIDER THERAPY | TREATMENT GOAL |
| ASCVD RISK |-------------------------------------|----------------------------------------|
| CATEGORY@ | LDL CHOLESTEROL| NON HDL CHLOESTEROL| LDL CHOLESTEROL | NON HDL CHLOESTEROL|
| | (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)| (LDL-C)(mg/dL) |(NON HDL-C) (mg/dL |
|--------------|----------------|--------------------|-------------------|--------------------|
|Extreme (A) | >=50 | >=80 |<50 (Indispensable)| <80 |
| | | |<30 (Optional) | |
|--------------|----------------|--------------------|-------------------|--------------------|
|Extreme (B) | >=30 | >=60 | <30 | <60 |
|--------------|----------------|--------------------|-------------------|--------------------|
| Very High | >=50 | >=80 | <50 | <80 |
|--------------|----------------|--------------------|-------------------|--------------------|
| High | >=70 | >=100 | <70 | <100 |
|--------------|----------------|--------------------|-------------------|--------------------|
| Moderate | >=100 | >=130 | <100 | <130 |
|--------------|----------------|--------------------|-------------------|--------------------|
| Low | >=130* | >=160* | <100 | <130 |
---------------------------------------------------------------------------------------------
* In low risk patient, consider therapy after an initial non-pharmacological intervention for at least 3 months

@To know your risk category click on bit.ly link sent on your registered mobile number, answer the
questionnaire, the ASCVD risk report can be downloaded from website

*454015753* Page 5 of 7
.

Name : Mrs. MAMTA SHUKLA

Lab No. : 454015753 Age : 42 Years
Ref By : SELF Gender : Female
Collected : 9/9/2023 10:10:00AM Reported : 10/9/2023 2:03:43AM
A/c Status : P Report Status : Final
Collected at : NOIDA II, (SECTOR 50) Processed at : LPL-NOIDA LAB
B-1/1, Central Market, Sec-50, Noida-201304 T. N-27, SECTOR-18, NOIDA - 201301
LTD, Phone no.-0120-3988505
NOIDA

Test Report
Test Name Results Units Bio. Ref. Interval

COMPLETE BLOOD COUNT;CBC

(Photometry, Electrical Impedance, VCS Technology & Calculated)

Hemoglobin 11.50 g/dL 12.00 - 15.00

Packed Cell Volume (PCV) 34.90 % 36.00 - 46.00

RBC Count 4.58 mill/mm3 3.80 - 4.80

MCV 76.30 fL 83.00 - 101.00

MCH 25.20 pg 27.00 - 32.00

MCHC 33.00 g/dL 31.50 - 34.50

Red Cell Distribution Width (RDW) 15.50 % 11.60 - 14.00

Total Leukocyte Count (TLC) 5.50 thou/mm3 4.00 - 10.00

Differential Leucocyte Count (DLC)

Segmented Neutrophils 63.00 % 40.00 - 80.00
Lymphocytes 28.30 % 20.00 - 40.00
Monocytes 5.60 % 2.00 - 10.00
Eosinophils 2.10 % 1.00 - 6.00
Basophils 1.00 % <2.00
Absolute Leucocyte Count
Neutrophils 3.47 thou/mm3 2.00 - 7.00
Lymphocytes 1.56 thou/mm3 1.00 - 3.00
Monocytes 0.31 thou/mm3 0.20 - 1.00
Eosinophils 0.12 thou/mm3 0.02 - 0.50
Basophils 0.06 thou/mm3 0.02 - 0.10
Platelet Count 243 thou/mm3 150.00 - 410.00

Mean Platelet Volume 9.5 fL 6.5 - 12.0

Note
1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of

*454015753* Page 6 of 7
.

Name : Mrs. MAMTA SHUKLA

Lab No. : 454015753 Age : 42 Years
Ref By : SELF Gender : Female
Collected : 9/9/2023 10:10:00AM Reported : 10/9/2023 2:03:43AM
A/c Status : P Report Status : Final
Collected at : NOIDA II, (SECTOR 50) Processed at : LPL-NOIDA LAB
B-1/1, Central Market, Sec-50, Noida-201304 T. N-27, SECTOR-18, NOIDA - 201301
LTD, Phone no.-0120-3988505
NOIDA

Test Report
Test Name Results Units Bio. Ref. Interval
blood

2. Test conducted on EDTA whole blood

Dr Parul Joshi Dr Swati Singh

MD, Pathology MD, Pathology
Chief of Laboratory Chief of Laboratory
Dr Lal PathLabs Ltd Dr Lal PathLabs Ltd

-------------------------------End of report --------------------------------

AHEEEHAPMKHIFJFNLOHHEJLCBILLJCECCJICIKPJNKEDFEFAPPAHEEEHA
BNFFFNBPAPBCICFGFGECBOIPAOAHFHAKAKJOBCJKFLELNOJGMPBNFFFNB
GMDABGFNLNNBGPKNHFIAAJHFJHFEHEDDLKPHENFLMKLMOEFLBLHDEHANP
DJBDKAFNBGOIELEANKOELEPFAFHLAKAFJIFFPAPAKKNJPDNLILNBKEMEL
IALGJLFIONBFDIACIDNGMHBEJENLKLAHKKMDEMMIPLKGKPNGKFFFOOMIG
PGCBBEFDPECAMIHKIIFFKIPBADHFOFAINCECBKDLBLIKOMNALNEJOOMCD
DJIMIJFBALOOFACIEOIMKGGHIHAFJBAKOFOPBLMMOJCHKNFMIJNFIDILD
BNFNAMFMAJNAIICMAANHDCIILLBMFMBFIFCCAMNNIJKDKPNGBNFNBHILL
NKALDNFKIDJGFEIDIOMIHJNKHENFEKFBJFFLAKPFOEBIOCNKDJPHNEKLJ
POHBKAFCEHAJJDCFFKGOIDJLDDFKPNJHKEPHEDFLNKCKIGEOCIDKHMCNK
HGIKNMFLGKKKNPAMPAEBGJEEINMHFGFBJMEEBFOEONDMKPFKEPCIGKAEO
IOICGJFMMLDNIFAMHPCNBPCEIEOPPFOFBMHPBLNOOLJAIANINKONHDICL
MNNNNNEHCFDCIKIAGCFLHBDHJBAHFHADNKPFCMNLMKJIPFNIAHFHAHIKL
APBBBPAPBJAAEBFFINBKCAMFAHGCHHCAONFFOKPGOLMHNLNNEDFDGBKHH
HHHHHHHPHHPPHPPPHPPPPHPPHHPPPPPPPPPHHPHPPHHHPHPHHHHPHHPHP

IMPORTANT INSTRUCTIONS
ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory .
ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .ŸReport
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost
for derivation of exact value. Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations .ŸThe
Courts/Forum at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).ŸTest results are not valid
for medico legal purposes.ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical
Practitioner/Doctor. ŸThe report does not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: lalpathlabs@lalpathlabs.com

*454015753* Page 7 of 7